International Multi-centre PEComa Ambispective Cohort Trial- IMPACT (a PUSH platform study) - Studio internazionale multicentrico ambispettico di coorte sul PEComa - IMPACT (uno studio della piattaforma PUSH)

Title

Code

PEComa_IMPACT

Type

Osservazionale

Start Year

2026

Status

In Corso

Principal Investigator

051-6366102

toni.ibrahim@ior.it

Ibrahim Toni, BSc, MSc, MD, PhD

Director

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies

Operational unit that carry out the study

complex unit

Osteoncologia, Sarcomi dell'osso e dei tessuti molli, e Terapie Innovative

Director

Ibrahim Toni, BSc, MSc, MD, PhD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. PEComa_IMPACT

Friday 14 August 2026, 13:25

PG0010661_2026_Stampa_unica.pdf

Attachment

Informativa Privacy (adulti)

Friday 14 August 2026, 13:23

09_Informativa_dati_genetici_ceavec_adulti_v.1.0_PEComa-IMPACT-1_SSAR.pdf

Attachment

Informativa Privacy (minori)

Friday 14 August 2026, 13:21

09_Informativa_dati_genetici_ceavec_minori_v.1.0_PEComa-IMPACT-1_SSAR_clean.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

International Multi-centre PEComa Ambispective Cohort Trial- IMPACT (a PUSH platform study) - Studio internazionale multicentrico ambispettico di coorte sul PEComa - IMPACT (uno studio della piattaforma PUSH)

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in